Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients
- PMID: 27604423
- DOI: 10.1007/s12094-016-1536-7
Clinical behavior of solitary fibrous tumor: a retrospective review of 30 patients
Abstract
Background: Solitary fibrous tumors (SFTs) are a rare type of soft tissue sarcoma of unpredictable clinical behavior. Some clinicopathologic characteristics have also been related to patient outcome.
Methods: This study is a retrospective review of 30 patients. We analyzed the clinical course and pathological factors to predict recurrence.
Results: The mean age was 55.9 years. Forty-five percent were located in the thoracic region. The mean tumor size was 10 cm (max24). Thirty-three percent had a relapse and 20 % have died. Median time to relapse was 7.18 (1-13) years. Median overall survival (OS) was 15.5 years (0-32). On histopathologic analysis, 6 % percent had >4 mitoses, 23 % had necroses, and 36 % had atypia/pleomorphism. Forty-three percent had tumor size >10 cm. Forty-six percent had at least one characteristic of malignancy. None of this data could predict clinical behavior by itself.
Conclusions: SFT can be an aggressive disease and relapses can occur several years from diagnosis. We did not find any clinicopathologic factors that could predict the tumor behavior accurately. Nevertheless, it should be consider that we included different tumor locations and the sample size is small.
Keywords: Chemotherapy; Pathology; Sarcoma; Solitary fibrous tumor; Tumor biology.
Similar articles
-
Prognosis of solitary fibrous tumors: a multicenter study.Ann Surg Oncol. 2013 Dec;20(13):4090-5. doi: 10.1245/s10434-013-3242-9. Epub 2013 Sep 20. Ann Surg Oncol. 2013. PMID: 24052313
-
Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors.Ann Surg Oncol. 2017 Dec;24(13):3865-3871. doi: 10.1245/s10434-017-6092-z. Epub 2017 Oct 16. Ann Surg Oncol. 2017. PMID: 29039030 Clinical Trial.
-
Malignant fat-forming solitary fibrous tumor (so-called "lipomatous hemangiopericytoma"): clinicopathologic analysis of 14 cases.Am J Surg Pathol. 2011 Aug;35(8):1177-85. doi: 10.1097/PAS.0b013e318219cd0b. Am J Surg Pathol. 2011. PMID: 21716088
-
Orbit Solitary Fibrous Tumor: A Proposed Risk Prediction Model Based on a Case Series and Comprehensive Literature Review.Head Neck Pathol. 2021 Mar;15(1):138-152. doi: 10.1007/s12105-020-01184-6. Epub 2020 Jun 11. Head Neck Pathol. 2021. PMID: 32529350 Free PMC article. Review.
-
Myxoid solitary fibrous tumor: a study of three cases.Int J Surg Pathol. 2013 Aug;21(4):358-62. doi: 10.1177/1066896912470166. Epub 2012 Dec 17. Int J Surg Pathol. 2013. PMID: 23248341 Review.
Cited by
-
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour.Br J Cancer. 2022 Nov;127(10):1793-1798. doi: 10.1038/s41416-022-01959-4. Epub 2022 Aug 27. Br J Cancer. 2022. PMID: 36030294 Free PMC article.
-
Solitary Fibrous Tumor of Pancreas With Unusual Features: A Case Report.Cureus. 2020 Oct 6;12(10):e10833. doi: 10.7759/cureus.10833. Cureus. 2020. PMID: 33173639 Free PMC article.
-
Case report: A case of giant malignant solitary fibrous tumor of the pleura with Doege-Potter's syndrome and review of the literature.Front Oncol. 2024 Nov 29;14:1437535. doi: 10.3389/fonc.2024.1437535. eCollection 2024. Front Oncol. 2024. PMID: 39678506 Free PMC article.
-
Demographic and Clinical Characteristics of Malignant Solitary Fibrous Tumors: A SEER Database Analysis.Cancers (Basel). 2024 Sep 29;16(19):3331. doi: 10.3390/cancers16193331. Cancers (Basel). 2024. PMID: 39409953 Free PMC article.
-
Risk factors for recurrent disease after resection of solitary fibrous tumor: a systematic review.Front Surg. 2024 Jan 31;11:1332421. doi: 10.3389/fsurg.2024.1332421. eCollection 2024. Front Surg. 2024. PMID: 38357190 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources